David Geffen School of Medicine at UCLA
Cedars-Sinai Medical Center
Charles R. Drew University of Medicine and Science
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
We do not support your browser. Please take a moment and
upgrade to the most recent version
of Internet Explorer.
Researcher Resources
Education & Training
Community Engagement
Funding
Overview
Log In or Register
CTSI Faculty Search
Main
CTSI Distinguished
Speaker Series
Human Subjects &
Clinical Trials
Letter of Support
Research Cores
Boilerplate Text
Grant Library
Clinical & Translational
Research Centers (CTRCs)
Trial Innovation
Network (TIN)
Clinical Data Requests
Biostatistical Services
Events
view all
SEP 21
Grants Submission Unit and Trial Innovation Network Office Hours
SEP 22
Drop-In Statistical Consults at UCLA
SEP 23
Grants Submission Unit and Trial Innovation Network Office Hours
SEP 24
Drop-In Statistical Consults at UCLA
SEP 28
Grants Submission Unit and Trial Innovation Network Office Hours
SEP 29
“Targeting monoamine oxidase A for cancer immunotherapy” - Lili Yang, Ph.D., UCLA
SEP 29
Drop-In Statistical Consults at UCLA
SEP 30
Grants Submission Unit and Trial Innovation Network Office Hours
CTSI Distinguished Speaker Series
Deadlines
view all
SEP 27
CTSA Un-Meeting RFA: Feature Your CTSI Research Topic, Hear from Experts
OCT 01
NSF Development Grants: Predictive Intelligence for Pandemic Prevention Phase I
OCT 08
UCLA CTSI R Grant Writing Two-Day Virtual Workshop (draft applications due)
OCT 11
Solve ME/CFS Initiative Pilot Funding
NOV 01
UCLA CTSI R Grant Writing Two-Day Virtual Workshop (general registration due)
NOV 30
NCI Physician-Scientist Early Investigator Program (PEIP)
News
archive
UCLA CTSI Featured Among CTSA Hubs Supporting Vaccination in Their Communities Against COVID-19
Scientists Develop Brain Organoids with Complex Neural Activity
Nanotech Device can Detect Risk for Serious Complication during Pregnancy
High-impact Commentary About Low-value Care Discussed on Health Affairs Blog
Re-engineering the Clinical Research Enterprise in Response to COVID-19: The CTSA Experience
“Targeting monoamine oxidase A for cancer immunotherapy” - Lili Yang, Ph.D., UCLA
